| Title : NLGN4X TCR transgenic T cells to treat gliomas - Kramer_2023_Neuro.Oncol__ |
| Author(s) : Kramer C , Kilian M , Chih YC , Kourtesakis A , Hoffmann DC , Boschert T , Koopmann P , Sanghvi K , De Roia A , Jung S , Jahne K , Day B , Shultz LD , Ratliff M , Harbottle R , Green EW , Will R , Wick W , Platten M , Bunse L |
| Ref : Neuro Oncol , : , 2023 |
| Abstract : Kramer_2023_Neuro.Oncol__ |
| ESTHER : Kramer_2023_Neuro.Oncol__ |
| PubMedSearch : Kramer_2023_Neuro.Oncol__ |
| PubMedID: 37715782 |
| Gene_locus related to this paper: human-NLGN4X , mouse-4neur |
| Title : NDRG1 prognosticates the natural course of disease in WHO grade II glioma - Blaes_2014_J.Neurooncol_117_25 |
| Author(s) : Blaes J , Weiler M , Sahm F , Hentschel B , Osswald M , Czabanka M , Thome CM , Schliesser MG , Pusch S , Luger S , Winkler F , Radbruch A , Jugold M , Simon M , Steinbach JP , Schackert G , Tatagiba M , Westphal M , Tonn JC , Gramatzki D , Pietsch T , Hartmann C , Glimm H , Vajkoczy P , von Deimling A , Platten M , Weller M , Wick W |
| Ref : J Neurooncol , 117 :25 , 2014 |
| Abstract : Blaes_2014_J.Neurooncol_117_25 |
| ESTHER : Blaes_2014_J.Neurooncol_117_25 |
| PubMedSearch : Blaes_2014_J.Neurooncol_117_25 |
| PubMedID: 24395351 |
| Title : mTOR target NDRG1 confers MGMT-dependent resistance to alkylating chemotherapy - Weiler_2014_Proc.Natl.Acad.Sci.U.S.A_111_409 |
| Author(s) : Weiler M , Blaes J , Pusch S , Sahm F , Czabanka M , Luger S , Bunse L , Solecki G , Eichwald V , Jugold M , Hodecker S , Osswald M , Meisner C , Hielscher T , Rubmann P , Pfenning PN , Ronellenfitsch M , Kempf T , Schnolzer M , Abdollahi A , Lang F , Bendszus M , von Deimling A , Winkler F , Weller M , Vajkoczy P , Platten M , Wick W |
| Ref : Proc Natl Acad Sci U S A , 111 :409 , 2014 |
| Abstract : Weiler_2014_Proc.Natl.Acad.Sci.U.S.A_111_409 |
| ESTHER : Weiler_2014_Proc.Natl.Acad.Sci.U.S.A_111_409 |
| PubMedSearch : Weiler_2014_Proc.Natl.Acad.Sci.U.S.A_111_409 |
| PubMedID: 24367102 |